Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) Director William M. Sullivan sold 6,038 shares of the firm's stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $25.04, for a total value of $151,191.52. Following the sale, the director now directly owns 5,857,198 shares of the company's stock, valued at approximately $146,664,237.92. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Privia Health Group Stock Down 4.0 %

Shares of PRVA stock traded down $1.01 during mid-day trading on Thursday, reaching $24.22. 727,691 shares of the stock traded hands, compared to its average volume of 835,508. The stock's fifty day simple moving average is $28.27 and its two-hundred day simple moving average is $32.18. Privia Health Group, Inc. has a 1-year low of $17.99 and a 1-year high of $44.64. The company has a market cap of $2.77 billion, a price-to-earnings ratio of -67.28 and a beta of 0.66.

Privia Health Group (NASDAQ:PRVA – Get Rating) last announced its quarterly earnings results on Thursday, November 10th. The company reported $0.01 EPS for the quarter. Privia Health Group had a negative return on equity of 6.82% and a negative net margin of 3.02%. The firm had revenue of $342.90 million for the quarter, compared to analyst estimates of $323.66 million. On average, equities research analysts anticipate that Privia Health Group, Inc. will post -0.25 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in PRVA. BlackRock Inc. lifted its stake in shares of Privia Health Group by 108.4% in the first quarter. BlackRock Inc. now owns 2,579,166 shares of the company's stock worth $68,940,000 after acquiring an additional 1,341,730 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Privia Health Group by 71.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,780,204 shares of the company's stock worth $80,960,000 after acquiring an additional 1,162,270 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Privia Health Group by 34.1% in the first quarter. Bank of New York Mellon Corp now owns 4,138,080 shares of the company's stock worth $110,611,000 after acquiring an additional 1,052,856 shares during the period. Macquarie Group Ltd. lifted its stake in shares of Privia Health Group by 967.2% in the second quarter. Macquarie Group Ltd. now owns 799,353 shares of the company's stock worth $23,277,000 after acquiring an additional 724,449 shares during the period. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Privia Health Group in the second quarter worth approximately $21,010,000. 62.81% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Company Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

• Get a free copy of the StockNews.com research report on Privia Health Group (PRVA)
• This is no Time to Buy Lennar but the Time is Coming
• Game-Changing News For Mullen Automotive
• Inflation and the Energy Crisis are Two Freight Trains on a Collision Course – Here's How to Prepare
• Is Enterprise Products Partners Fairly Valued?
• Will WhatsApp Partnership Boost MercadoLibre's Earnings?

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.